IDENTIFICATION OF FRAMEWORK RESIDUES REQUIRED TO RESTORE ANTIGEN-BINDING DURING RESHAPING OF A MONOCLONAL-ANTIBODY AGAINST THE GLYCOPROTEIN GB OF HUMAN CYTOMEGALOVIRUS

被引:18
作者
TEMPEST, PR
WHITE, P
BUTTLE, M
CARR, FJ
HARRIS, WJ
机构
[1] SCOTGEN BIOPHARMACEUT INC,ABERDEEN AB22 8GU,SCOTLAND
[2] UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN AB9 1AS,SCOTLAND
关键词
ANTIBODY; CYTOMEGALOVIRUS; HUMANIZATION;
D O I
10.1016/0141-8130(95)93516-Z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction of the complementary determining regions (CDRs) from a murine antibody to a human monoclonal antibody is an important technique (humanization) in the development of human immunotherapeutics. We have humanized murine monoclonal antibody HCMV37 which binds to the gB envelope glycoprotein of human cytomegalovirus. Simple transfer of the murine HCMV37 CDRs into heavy- and light-chain framework regions (FRs) based on human NEW and REI, respectively, together with human IgGI and K constant regions, abolished antigen binding because of a suboptimal heavy chain. Replacement of human VH amino acids Leu70, Val71 and Arg94 with murine residues Thr70, Arg71 and Asn94 was insufficient to improve affinity. However, significant restoration of binding was obtained by substitution of human VH amino acids Thr28, Phe29, Ser30 with murine residues Ser28, Ile29, Thr30, in conjunction with the position 94 change. Residue 71, often regarded as critical for antigen binding, was not a major factor.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 40 条
[21]   RAT MONOCLONAL ANTITUBULIN ANTIBODIES DERIVED BY USING A NEW NON-SECRETING RAT-CELL LINE [J].
KILMARTIN, JV ;
WRIGHT, B ;
MILSTEIN, C .
JOURNAL OF CELL BIOLOGY, 1982, 93 (03) :576-582
[22]   MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS [J].
MATHIESON, PW ;
COBBOLD, SP ;
HALE, G ;
CLARK, MR ;
OLIVEIRA, DBG ;
LOCKWOOD, CM ;
WALDMANN, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (04) :250-254
[23]  
NAKAMAYE K, 1988, NUCLEIC ACIDS RES, V14, P9679
[24]   CLONING IMMUNOGLOBULIN VARIABLE DOMAINS FOR EXPRESSION BY THE POLYMERASE CHAIN-REACTION [J].
ORLANDI, R ;
GUSSOW, DH ;
JONES, PT ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3833-3837
[25]   STRUCTURE OF AN ANTIBODY ANTIGEN COMPLEX - CRYSTAL-STRUCTURE OF THE HYHEL-10 FAB-LYSOZYME COMPLEX [J].
PADLAN, EA ;
SILVERTON, EW ;
SHERIFF, S ;
COHEN, GH ;
SMITHGILL, SJ ;
DAVIES, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5938-5942
[26]   ANATOMY OF THE ANTIBODY MOLECULE [J].
PADLAN, EA .
MOLECULAR IMMUNOLOGY, 1994, 31 (03) :169-217
[27]   VIRAL POLYPEPTIDES DETECTED BY A COMPLEMENT-DEPENDENT NEUTRALIZING MURINE MONOCLONAL-ANTIBODY TO HUMAN CYTOMEGALO-VIRUS [J].
RASMUSSEN, L ;
MULLENAX, J ;
NELSON, R ;
MERIGAN, TC .
JOURNAL OF VIROLOGY, 1985, 55 (02) :274-280
[28]   RESHAPING HUMAN-ANTIBODIES FOR THERAPY [J].
RIECHMANN, L ;
CLARK, M ;
WALDMANN, H ;
WINTER, G .
NATURE, 1988, 332 (6162) :323-327
[29]  
Routledge E.G., 1993, PROTEIN ENG ANTIBODY, P13
[30]  
Sambrook J., 1989, MOL CLONING LAB MANU